Azacitidine delivers dramatic results in patients with high-risk myelodysplastic syndromes

被引：0
作者：
Fenaux, P.
Mufti, G. J.
Hellstrom-Lindberg, E.
机构：
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2009年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [21] Treatment of high-risk myelodysplastic syndromes
    Fenaux, Pierre
    HEMATOLOGIE, 2006, 12 : 12 - 13
  • [22] Management of high-risk myelodysplastic syndromes
    Pisani, FD
    Rainaldi, A
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 40 (03) : 215 - 228
  • [23] Treating high-risk myelodysplastic syndromes
    Ades, Lionel
    BULLETIN DU CANCER, 2023, 110 (11) : 1162 - 1167
  • [24] Treatment of high-risk myelodysplastic syndromes
    Kroeger, Nicolaus
    HAEMATOLOGICA, 2025, 110 (02) : 339 - 349
  • [25] FAS Gene Expression Is Epigenetically Regulated and Predicts the Responsiveness to Azacitidine In High-Risk Myelodysplastic Syndromes
    Ettou, Sandrine
    Humbrecht, Catherine
    Benet, Blandine
    Kosmider, Olivier
    Droin, Nathalie
    Beyne-Rauzy, Odile
    Quesnel, Bruno
    Lacombe, Catherine
    Francois, Dreyfus
    Mayeux, Patrick
    Solary, Eric
    Fontenay, Michaela
    BLOOD, 2010, 116 (21) : 107 - 108
  • [26] COSTEFFECTIVENESS OF AZACITIDINE FOR THE TREATMENT OF IPSS INT-2 OR HIGH-RISK MYELODYSPLASTIC SYNDROMES IN THE UK
    Brereton, N.
    Murthy, A.
    Akehurst, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 131 - 131
  • [27] DECITABINE IN TREATMENT OF PATIENTS WITH INTERMEDIATEOR HIGH-RISK MYELODYSPLASTIC SYNDROMES
    Kalinichenko, E.
    Ponteleeva, I.
    Fiodarava, A.
    Iskrov, I.
    Uss, A.
    LEUKEMIA RESEARCH, 2017, 55 : S71 - S72
  • [28] Azacitidine in the management of patients with myelodysplastic syndromes
    Khan, Cyrus
    Pathe, Neeta
    Fazal, Salman
    Lister, John
    Rossetti, James M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (06) : 355 - 373
  • [29] Impact of Venetoclax on High-Risk Myelodysplastic Syndromes: A Retrospective Multicenter Analysis of Azacitidine-Venetoclax vs Azacitidine Monotherapy in Mexico
    Chacon-Rangel, Lyam Carlo
    Rodriguez-Rodriguez, Sergio
    Ontiveros-Austria, Juan Luis
    Demichelis-Gomez, Roberta
    Gomez-De Leon, Andres
    Rodriguez-Zuniga, Anna C.
    Inclan-Alarcon, Sergio Ignacio
    Corral-Herrera, Veronica Steffania
    Zapata-Canto, Nidia Paulina
    Apodaca-Chavez, Elia Ixel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S396 - S397
  • [30] Azacitidine in lower-risk myelodysplastic syndromes
    Santini, Valeria
    LEUKEMIA RESEARCH, 2009, 33 : S22 - S26
12345